ZYME- Zymeworks Inc.

Name: Zymeworks Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zymeworks Inc. (ZYME) has 14 insiders with recent SEC Form 4 filings, including 23 buys and 2 sells. ZYME is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Galbraith Kenneth	257.3K	$6.32M	-
CFO	Stafford Kristin	178.0K	$4.37M	-
COO	Hollywood Mark	66.0K	$1.62M	-
Other	Moore Paul Andrew	58.1K	$1.43M	-
VP	Smith Jeffrey T L	36.0K	$885.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 4, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	317,208	$11.42	$3,623,970.36	+0.9%	+19.1%	+136.0%
Apr 2, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	127,415	$11.75	$1,497,322.33	+0.2%	+4.1%	+116.4%
Mar 26, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	97,349	$12.61	$1,227,309.18	+0.3%	+3.8%	+99.9%
Mar 24, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	127,198	$12.92	$1,643,247.98	+0.2%	-4.4%	+80.8%
Mar 19, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	228,463	$12.55	$2,866,552.72	+0.5%	-4.3%	+86.8%
Mar 13, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	1,081,980	$12.13	$13,120,914.17	+2.2%	+2.6%	+82.3%
Jan 17, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	141,429	$13.88	$1,963,538.26	+0.5%	-16.9%	+69.1%
Jan 15, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	167,654	$13.59	$2,278,811.37	+0.4%	-22.1%	+68.3%
Jan 10, 2025	Ecor1 Capital, LLC76	Director, 10% Owner	Buy	225,119	$13.21	$2,974,818.88	+0.7%	-28.6%	+75.3%
Jan 6, 2025	Moore Paul Andrew	Chief Scientific Officer	Sale+OE	21,200	$14.92	$316,390.92	-35.8%	-27.9%	+67.2%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC